GSK Investigational Site

Park Ridge, Illinois 60068

0 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome, Asthma, Bipolar Disorder, Chemotherapy-Induced Nausea and Vomiting, Depressive Disorder, Major, Lung Cancer, Non-Small Cell, Metastatic Breast Cancer, Migraine Disorders, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Obstetric Labour, Premature, Post-Traumatic Stress Disorder

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor — Stopped early
• Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies — Completed
• Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma — Stopped early
• Clinical Study to Test a New Drug to Treat Major Depression — Completed
• Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder — Completed
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• Migraine Study in Adolescent Patients — Completed
• Advair Pediatric Once-Daily — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy — Completed
• Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. — Completed
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
• Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer — Completed